MODACARE 400

What is MODACARE 400?

MODACARE 400 is a medicinal product in the form of tablets for oral administration, containing the active ingredient modafinil at a dosage of 400 mg. The agent belongs to the pharmacological group of nootropic drugs and agents that help maintain a state of active wakefulness by affecting certain structures of the central nervous system. The manufacturer of MODACARE 400 is the pharmaceutical company Careclub, which specializes in the production of products to support cognitive functions and mental performance. The drug is presented in the form of solid tablets intended for oral administration, which ensures ease of dosage and a systemic effect on the body. MODACARE 400 is not a classic psychostimulant of the amphetamine series, although its activity is associated with the modulation of dopaminergic and noradrenergic transmission.

The pharmacological action of MODACARE 400 is realized through the effect on the hypothalamic centers responsible for the regulation of the sleep-wake cycle. Unlike traditional stimulants, modafinil acts more selectively, reducing excessive daytime sleepiness without pronounced excitation of the peripheral nervous system. This allows patients to maintain clarity of thought, concentration, and the ability to perform complex intellectual tasks over a long period. The drug is used in medical practice for the correction of conditions associated with pathological sleepiness, as well as in the complex therapy of attention disorders. It is important to understand that MODACARE 400 is a prescription agent, and its administration should be carried out exclusively by a doctor after a thorough examination.

The therapeutic effect of MODACARE 400 develops gradually, reaching maximum plasma concentration two to three hours after oral administration. The elimination half-life of the active substance is about twelve to fifteen hours, which provides a long-lasting effect throughout the day without the need for frequent repeated dosing. The metabolism of the drug occurs mainly in the liver with the participation of enzymes of the cytochrome P450 system, and the excretion of metabolites is carried out by the kidneys. Such a pharmacokinetic profile allows for predicting a stable clinical effect provided the recommended regimen is followed. MODACARE 400 by Careclub is manufactured in accordance with international quality standards, which guarantees an appropriate level of purification of the active substance and minimization of impurities.

What is MODACARE 400 prescribed for?

The main indication for the use of MODACARE 400 is narcolepsy — a chronic neurological disorder characterized by uncontrollable attacks of sleep during the day and sudden loss of muscle tone. The drug helps patients with this diagnosis maintain a sufficient level of wakefulness during the daytime, reducing the frequency and intensity of episodes of sudden falling asleep. Due to its modulating effect on the orexin system of the hypothalamus, MODACARE 400 stabilizes circadian rhythms and improves the overall quality of life of patients. Clinical studies demonstrate a significant reduction in daytime sleepiness scores on the Epworth scale after the first weeks of therapy.

The second important area of application for MODACARE 400 is obstructive sleep apnea syndrome, when patients suffer from pronounced daytime fatigue even when using CPAP therapy. In such cases, the drug is prescribed as an adjuvant agent to overcome residual sleepiness and restore cognitive performance. MODACARE 400 is also used for shift work sleep disorder, when professional activity requires activity at night or during frequent time zone changes. The drug helps adapt the body to an unconventional schedule, reducing the risk of errors associated with fatigue and reduced attention.

In clinical practice, MODACARE 400 is sometimes used off-label to correct attention deficit hyperactivity disorder in adults, as well as to support cognitive functions in depressive states accompanied by apathy and reduced energy levels. However, such use should take place exclusively under strict medical supervision, taking into account the individual characteristics of the patient. It is important to emphasize that unauthorized use of MODACARE 400 to increase mental performance by healthy individuals is not recommended and can lead to undesirable consequences. Prescription of the drug requires a preliminary examination of the cardiovascular system and an assessment of mental status.

Composition and active components of MODACARE 400

The main active substance of MODACARE 400 is modafinil — a synthetic compound belonging to the class of benzhydrylsulfinylacetamides. The mechanism of action of modafinil consists in inhibiting the reuptake of dopamine in the synaptic cleft, which leads to an increase in the concentration of this neurotransmitter in the prefrontal cortex and hypothalamus. Additionally, modafinil affects histaminergic, noradrenergic, and glutamatergic systems, creating a complex effect of activating cognitive processes. Unlike amphetamines, modafinil does not cause pronounced euphoria, tremor, or peripheral sympathomimetic activation, which accounts for its more favorable safety profile.

Excipients in MODACARE 400 include microcrystalline cellulose, croscarmellose sodium, povidone, magnesium stearate, and lactose monohydrate. These substances provide the proper technological properties of the tablet mass, the stability of the drug during its shelf life, and the uniform release of the active substance in the gastrointestinal tract. Lactose monohydrate acts as a filler, and magnesium stearate acts as an anti-adhesive agent preventing components from sticking together during production. Croscarmellose sodium promotes rapid disintegration of the tablet after entering the stomach, which accelerates the onset of therapeutic action.

The pharmacodynamics of modafinil is characterized by a dose-dependent effect on cognitive functions, with a dosage of 400 mg providing the most pronounced and long-lasting effect compared to lower doses. The active substance of MODACARE 400 selectively activates neurons of the lateral hypothalamus that produce orexin — a neuropeptide responsible for maintaining wakefulness. Simultaneously, the drug modulates the activity of the ventrolateral preoptic nucleus, which plays a key role in initiating sleep processes. Such a dual mechanism makes it possible to achieve a sustained therapeutic result without depleting neurotransmitter stores, which is characteristic of classic psychostimulants.

Dosage of MODACARE 400

The standard recommended dose of MODACARE 400 for adult patients is one 400 mg tablet per day, taken in the morning or one hour before starting a work shift. For patients with narcolepsy or obstructive sleep apnea syndrome, such a regimen provides adequate control of daytime sleepiness throughout the entire period of activity. In cases where the clinical response is insufficient or side effects are observed, the doctor may consider adjusting the dose by dividing the tablet or switching to a lower dosage. Changing the dosage independently without consulting a specialist is strictly not recommended, as this can lead to unpredictable reactions.

The duration of the treatment course with MODACARE 400 is determined individually depending on the diagnosis, severity of symptoms, and the patient's response to therapy. In chronic conditions such as narcolepsy, the drug can be used long-term with periodic evaluations of efficacy and safety by a doctor. For individuals with shift work sleep disorder, MODACARE 400 is prescribed situationally, only on days when increased alertness is required at night. Elderly patients may require a dose reduction due to slowed metabolism and increased sensitivity to active substances. In case of impaired liver or kidney function, the dosage is also subject to adjustment.

The maximum daily dose of MODACARE 400 should not exceed 400 mg, as a further increase in dose is not accompanied by a proportional increase in therapeutic effect, but significantly increases the risk of side effects. A missed regular dose should not be compensated for by taking a double dose the next day, as this can cause excessive stimulation of the nervous system and sleep disturbances. If signs of overdose appear, such as severe agitation, tachycardia, anxiety, or insomnia, immediate medical attention should be sought. A doctor may prescribe symptomatic therapy and monitoring of vital functions.

How to take MODACARE 400 correctly?

MODACARE 400 should be taken in the morning, immediately after waking up, swallowed with a sufficient amount of water. Taking the drug in the afternoon can lead to significant disruptions in night sleep, so it is important to adhere to the morning schedule. The tablet can be taken regardless of food intake, however, consumption with food may slightly delay the absorption of the active substance and postpone the onset of action. To achieve a stable therapeutic effect, it is recommended to take MODACARE 400 daily at the same time, which contributes to the formation of a predictable pharmacokinetic curve.

If a patient missed taking MODACARE 400, the tablet should be taken as soon as possible, but only provided that there are at least eight to ten hours left until the next scheduled intake. If the omission is noticed closer to the evening, it is better to skip taking it on that day and return to the usual schedule the following morning. During therapy with MODACARE 400, it is necessary to maintain an adequate level of hydration, as the drug can reduce the sensation of thirst and contribute to dehydration. It is also important to ensure sufficient night sleep, as the drug does not replace the body's physiological need for recovery.

Special attention should be paid to the individual reaction of the body to MODACARE 400 during the first days of use. Some patients may experience excessive vigor or mild anxiety, which usually passes after an adaptation period. If there is a history of cardiovascular diseases, arterial hypertension, or mental disorders, mandatory consultation with a doctor is required before starting the intake. MODACARE 400 should not be combined with other stimulating agents, including high doses of caffeine, as this can lead to excessive strain on the cardiovascular system and the development of anxiety states.

Side effects of MODACARE 400

The most common side effects of MODACARE 400 are headache, nervousness, insomnia, and reduced appetite. These symptoms usually occur at the beginning of therapy and are transient, gradually diminishing during the first to second week of administration. Headache may be associated with the vasoconstrictive effect of modafinil on cerebral vessels, so patients are recommended to maintain adequate hydration levels. Insomnia is most often observed when the dosing regimen is violated, particularly when taking the tablet after noon, so it is important to strictly adhere to the morning schedule. Reduced appetite can lead to gradual weight loss, requiring monitoring of nutritional status.

Less common adverse reactions of MODACARE 400 include tachycardia, increased blood pressure, palpitations, and dyspeptic disorders. Patients with a labile cardiovascular system require regular monitoring of hemodynamic parameters throughout the course of treatment. Gastrointestinal issues such as nausea, dry mouth, diarrhea, or abdominal discomfort may occur, which usually resolve on their own. In rare cases, allergic reactions in the form of skin rash, itching, or hives are observed, requiring immediate discontinuation of the drug and medical advice. Rare but serious side effects include the development of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Psychiatric side effects of MODACARE 400 may include anxiety, agitation, irritability, and in isolated cases, depressive episodes. Patients with a history of psychiatric illness have an increased risk of symptom exacerbation and therefore require particularly close supervision. If suicidal thoughts, severe anxiety, or psychotic symptoms appear, urgent medical assistance must be sought. Cases of dependence on modafinil with long-term use of high doses have also been reported, emphasizing the importance of adhering to the prescribed dosage regimen. Any unusual symptoms during therapy with MODACARE 400 should be discussed with a doctor for timely treatment adjustment.

Contraindications of MODACARE 400

Absolute contraindications to the use of MODACARE 400 are hypersensitivity to modafinil or any excipient of the drug. Patients with severe cardiovascular diseases, including uncontrolled arterial hypertension, ischemic heart disease, arrhythmias, and hypertrophic cardiomyopathy, should not take this agent due to the risk of complications. MODACARE 400 is contraindicated in the presence of a history of psychotic disorders, severe depression with suicidal tendencies, and bipolar affective disorder, as the drug may provoke an exacerbation of psychiatric symptoms. The drug is also not prescribed to patients with severe hepatic impairment due to altered metabolism of the active substance.

Pregnancy and lactation are absolute contraindications to the use of MODACARE 400, as safety data for modafinil regarding the fetus and newborn are lacking. Animal studies have shown potential teratogenic effects, so women of childbearing potential are recommended to use reliable methods of contraception during therapy. The drug is not prescribed to children and adolescents under eighteen years of age due to insufficient clinical data regarding efficacy and safety in this age group. Elderly patients may take MODACARE 400 only after a careful assessment of the benefit-risk ratio, considering concomitant diseases and polypharmacy.

Relative contraindications to the use of MODACARE 400 are epilepsy and seizure disorders, as the drug can lower the seizure threshold. Patients with moderate hepatic or renal impairment require dose reduction and regular laboratory monitoring of the function of the respective organs. For individuals with a history of substance abuse, MODACARE 400 is prescribed with caution due to the potential risk of developing dependence. Before starting therapy, it is mandatory to inform the doctor about all existing diseases, allergic reactions, and medications taken regularly or episodically. Consultation with a doctor is a necessary condition for the safe use of MODACARE 400.

Interaction of MODACARE 400 with other drugs and alcohol

MODACARE 400 can interact with hormonal contraceptives, reducing their effectiveness through the induction of cytochrome P450 enzymes, particularly the CYP3A4 isoenzyme. Women taking oral contraceptives are recommended to use additional barrier methods of protection throughout the treatment course and for another month after its completion. Concomitant use of MODACARE 400 with anticoagulants such as warfarin requires regular monitoring of blood clotting parameters, as modafinil can alter their metabolism. The drug is also capable of enhancing the action of tricyclic antidepressants, selective serotonin reuptake inhibitors, and some antiepileptic agents, which requires adjustment of their dosage.

Alcohol consumption during therapy with MODACARE 400 is categorically not recommended, as ethanol can worsen the side effects of the drug and mask signs of intoxication. Combining modafinil with alcohol increases the risk of cardiovascular complications, heart rhythm disturbances, and unpredictable psychiatric reactions. In addition, MODACARE 400 can affect the speed of psychomotor reactions, so during treatment, one should refrain from driving vehicles and working with dangerous machinery until individual tolerance is established. Patients whose professional activity requires increased concentration must discuss with a doctor the possibility of safely performing work duties during therapy.

Where to buy MODACARE 400 in Ukraine

MODACARE 400 is available for purchase in pharmacy chains of Ukraine upon presentation of a doctor's prescription, as the drug belongs to the category of prescription medicines. Careclub products are also presented in specialized online pharmacies that deliver medications throughout the country in compliance with cold chain requirements and proper transportation conditions. When purchasing MODACARE 400, it is important to pay attention to the integrity of the packaging, expiration date, and the presence of protective elements confirming the authenticity of the product. It is recommended to buy the drug only at verified licensed sales points, avoiding doubtful sources.

MODACARE 400 should be stored in a dry place, protected from light, at a temperature not exceeding twenty-five degrees Celsius. The drug should be kept out of the reach of children, in its original packaging, which protects the tablets from moisture and air exposure. The shelf life is usually two to three years from the date of manufacture, after which the use of the drug is prohibited. Before starting to take MODACARE 400, it is necessary to carefully read the instructions and consult a doctor regarding the appropriateness of use, possible risks, and individual body reactions to the active components of the product.